Nitric oxide during heart surgery to protect the kidneys of newborns with heart defects
Tests nitric oxide for preventing kidney injury in newborns having heart surgery.
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Registry title
- NO During CPB in Neonates to Reduce Risk of AKI
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 40 people, planned
- Started
- 10 Jan 2023
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Nitric Oxide
- Oxygen
- Record updated
- 5 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for newborn babies up to 31 days old who are having heart surgery with a heart-lung machine (cardiopulmonary bypass) for a heart defect present from birth.
- Age
- 1 Day to 31 Days (≤31 days)
- Sex
- All
- Disease stage
- Congenital heart disease that needs heart surgery with cardiopulmonary bypass. Emergency surgery is not included.
- Earlier treatment
- Babies cannot join if they recently had steroids (except steroids given for the bypass) or had inhaled NO (iNO) right before surgery. Babies taking other investigational drugs cannot join.
Main reasons for not taking part
- Emergency surgery, or a cardiac arrest within 1 week before surgery
- Kidney injury before surgery, or kidney structure problems seen on ultrasound
- Signs of high blood pressure in the lungs that lasts, before surgery
- Weight less than 2 kg (4 lb), or born before 36 weeks of pregnancy
- Major birth defects outside the heart, or parents who do not speak English
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- All neonates (≤31 days) undergoing cardiac surgery with CPB for CHD will be deemed eligible for enrollment
Who cannot take part
- Emergency surgery,
- Episode of cardiac arrest within 1 week before surgery,
- Recent treatment with steroids and/or a condition that may require treatment with steroids (excluding steroid administration specifically for CPB),
- Use of inhaled NO (iNO) immediately prior to surgery,
- Use of other investigational drugs,
- Failure to obtain informed consent from parent/guardian
- Gestational age <36 weeks,
- Clinical signs of preoperative persistent elevated pulmonary vascular resistance,
- Structural renal abnormalities by ultrasound,
- Preoperative AKI,
- Weight less than <2 kg,
- Major extracardiac congenital anomalies,
- Non-English speakers
Where in United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: David S. Cooper, MDTaking people
About the trial
What the trial wants to find out
Acute kidney injury (AKI) following cardiac surgery for congenital heart defects (CHD) in children affects up to 60% of high risk-patients and is a major cause of both short- and long-term morbidity and mortality. Despite effort, to date, no successful therapeutic agent has gained widespread success in preventing this postoperative decline in renal function. Nitric oxide is an intricate regulator of acute inflammation and coagulation and is a potent vasodilator. The investigators hypothesize that nitric oxide, administered during cardiopulmonary bypass (CPB), may reduce the incidence of AKI.
The 2 groups in the trial
- Nitric OxideTreatment being tested
Intraoperative NO entrained at 20 ppm into the oxygenator of the CPB circuit with standard care
- OxygenPlacebo, for comparison
Standard CPB without NO administered at any point intraoperatively
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Nitric Oxide Administration During Cardiopulmonary Bypass in Neonates at Reducing the Risk of Acute Kidney Injury
- Plain-language title
- Nitric oxide during heart surgery to protect the kidneys of newborns with heart defectsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 5 August 2026